About the journal
Thrombosis Journal is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,590 EUR. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 1477-9560
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,590 EUR
- Articles in DOAJ
- 924
- Declared review time
- 16 weeks
- Declared peer-review model
- other
- Official website
- https://thrombosisjournal.biomedcentral.com
Index listings
- DOAJ · 2003-07-07
- PUBMED · 2003-05-06
- Indexing
- DOAJ · PUBMED
- APC
- 2,590 EUR
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
924
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
1081
Last recorded publication year
2026
h-index
63
i10-index
480
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2003-07-07
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- LOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 21%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- TJ
- Source type
- journal
- NLM unique ID (PubMed)
- 101170542
- Society affiliations
- Asian-Pacific Society on Thrombosis and Hemostasis
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Blood Coagulation and Thrombosis Mechanisms
- Blood Coagulation and Thrombosis Mechanisms
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
Show all subjects (75)
- Platelet Disorders and Treatments
- Atrial Fibrillation Management and Outcomes
- Heparin-Induced Thrombocytopenia and Thrombosis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- Acute Ischemic Stroke Management
- Blood properties and coagulation
- Blood properties and coagulation
- Blood properties and coagulation
- Cerebral Venous Sinus Thrombosis
- Antiplatelet Therapy and Cardiovascular Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Complement system in diseases
- COVID-19 Clinical Research Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Acute Myocardial Infarction Research
- Hemophilia Treatment and Research
- Hemophilia Treatment and Research
- Sepsis Diagnosis and Treatment
- Acute Myocardial Infarction Research
- Inflammatory Biomarkers in Disease Prognosis
- Sepsis Diagnosis and Treatment
- Acute Myocardial Infarction Research
- Sepsis Diagnosis and Treatment
- Heparin-Induced Thrombocytopenia and Thrombosis
- Hemophilia Treatment and Research
- Acute Ischemic Stroke Management
- Acute Ischemic Stroke Management
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Central Venous Catheters and Hemodialysis
- Central Venous Catheters and Hemodialysis
- Blood transfusion and management
- Cerebral Venous Sinus Thrombosis
- Cerebral Venous Sinus Thrombosis
- Complement system in diseases
- Vascular anomalies and interventions
- Complement system in diseases
- Diagnosis and Treatment of Venous Diseases
- Diagnosis and Treatment of Venous Diseases
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Systemic Lupus Erythematosus Research
- Cardiac tumors and thrombi
- Cardiac tumors and thrombi
- Cardiovascular and Diving-Related Complications
- Cardiac tumors and thrombi
- Genetic Associations and Epidemiology
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Blood groups and transfusion
- Coronary Interventions and Diagnostics
- Protease and Inhibitor Mechanisms
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Blood groups and transfusion
- Protease and Inhibitor Mechanisms
- Blood transfusion and management
- Liver Disease and Transplantation
- Liver Disease and Transplantation
- Blood transfusion and management
- Coronary Interventions and Diagnostics
- Coronary Interventions and Diagnostics
- Central Venous Catheters and Hemodialysis
Keywords (DOAJ)
- thrombosis
- antithrombotic
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ